inTest Corporation (NASDAQ:INTT) Expected to Post Earnings of $0.08 Per Share

Share on StockTwits

Equities analysts expect inTest Corporation (NASDAQ:INTT) to announce earnings of $0.08 per share for the current quarter, Zacks reports. Zero analysts have provided estimates for inTest’s earnings. inTest posted earnings of $0.23 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 65.2%. The business is scheduled to announce its next quarterly earnings report on Thursday, March 5th.

On average, analysts expect that inTest will report full-year earnings of $0.33 per share for the current fiscal year. For the next fiscal year, analysts forecast that the business will report earnings of $0.41 per share. Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that cover inTest.

inTest stock traded up $0.23 during midday trading on Friday, reaching $5.52. The company’s stock had a trading volume of 1,202 shares, compared to its average volume of 32,055. inTest has a fifty-two week low of $4.10 and a fifty-two week high of $7.88. The stock’s 50 day simple moving average is $4.87 and its 200 day simple moving average is $4.80.

inTest Company Profile

inTEST Corporation designs, manufactures, and markets thermal management products and semiconductor automated test equipment interface solutions worldwide. The company operates in two segments, Thermal Products (Thermal) and Electromechanical Semiconductor Products (EMS). The Thermal segment offers ThermoStream temperature management tools, MobileTemp systems, ThermoChambers, Thermal Platforms, ThermoChuck precision vacuum platform assemblies, Thermonics temperature conditioning products, and EKOHEAT and EASYHEAT induction heating systems.

Featured Story: What is a Call Option?

Get a free copy of the Zacks research report on inTest (INTT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for inTest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTest and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.